StarlinePS Enterprises Limited successfully completed its preferential allotment of equity shares and convertible warrants on 23rd March, 2026, raising significant capital through both instruments. The Board of Directors approved the allotment in their meeting held on Monday, following the in-principle approval granted by BSE Limited on 9th March, 2026.

Board Meeting Outcome

The company's Board of Directors meeting commenced at 07:00 p.m. and concluded at 07:38 p.m. on 23rd March, 2026. The meeting was conducted pursuant to Regulation 30 of the SEBI Listing Regulations and the special resolution passed by members at their Extra Ordinary General Meeting held on 24th February, 2026.

Equity Share Allotment Details

The company allotted 6,78,33,700 fully paid-up equity shares of face value Re. 1/- each to non-promoter investors on a preferential basis. The shares were issued at Rs. 6/- per share, including a premium of Rs. 5/- per share.

Impact on Share Capital

The preferential allotment significantly increased the company's paid-up equity share capital. Following the allotment, the capital structure transformed as detailed below:

Convertible Warrants Issuance

Simultaneously, the company allotted 48,00,00,000 convertible warrants to both promoters and non-promoters at Rs. 6/- per warrant. The company received an upfront payment of 25% of the issue price.

Subscription Outcome

The preferential issue witnessed strong investor interest, with the equity shares being nearly fully subscribed:

Major Investors

The allotment included diverse investor participation, with notable allocations to individuals and entities. Among the warrant holders, promoters Varshaben D Koradiya and Dhirajbhai Vaghjibhai Koradiya received significant allocations of 10,00,00,000 and 11,51,48,076 warrants respectively. Non-promoter investors Kamya Abhishek Kamdar and Piyush L Mavani each received 6,41,66,666 warrants, demonstrating substantial non-promoter participation in the fundraising exercise.

Regulatory Compliance

The allotment was conducted in accordance with SEBI regulations, with all securities subject to applicable lock-in restrictions under the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018. Each convertible warrant is exercisable into one fully paid-up equity share of face value Re. 1/- and can be converted in one or more tranches within the stipulated timeframe.

StarlinePS Enterprises Limited has scheduled a board meeting for March 23, 2026, to consider the allotment of equity shares and convertible warrants following BSE's in-principle approval for its ₹330 crore preferential issue. The company informed BSE Limited about the upcoming board meeting through a regulatory filing dated March 16, 2026.

Board Meeting Agenda and Timeline

The board meeting, scheduled for Monday, March 23, 2026, at the company's registered office, will focus on finalizing the allotment process for the previously approved securities. This development follows BSE Limited's in-principle approval granted through Letter No. LOD/PREF/TT/FIP/1836/2025-26 dated March 09, 2026.

Securities Allotment Structure

The board will consider the allotment of two categories of securities as part of the comprehensive ₹330 crore fundraising initiative. The allotment process represents the next crucial step following regulatory approval.

Regulatory Framework and Compliance

The board meeting notification, filed under Regulation 29 of SEBI Listing Regulations, demonstrates the company's adherence to mandatory disclosure requirements. Company Secretary and Compliance Officer Madhuriben Chhatrola signed the regulatory filing, ensuring proper corporate governance protocols.

Financial Impact and Strategic Significance

The upcoming allotment will complete the ₹330 crore capital raising exercise, with ₹42 crore from equity shares and ₹288 crore from convertible warrants. This substantial fundraising initiative positions StarlinePS Enterprises to strengthen its capital base and support future growth strategies. The company must complete post-allotment formalities within the regulatory timeline, including submission of listing applications within twenty days as mandated by SEBI ICDR Regulations.